James C. Mullen, CEO at Editas Medicine, Inc. (EDIT), bought 25,000 shares at $46.27 ($1.2M) on 2021-03-02, disclosed to the SEC on 2021-03-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| EDIT | BUY | 2018-05-22 | $380K | — | Filing → |
| PODD | BUY | 2017-11-14 | $169K | — | Filing → |
| PKI | SELL | 2014-11-17 | $389K | — | Filing → |